SOPH:NSD-Sophia Genetics SA (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 4.72

Change

0.00 (0.00)%

Market Cap

USD 0.31B

Volume

0.13M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-23 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+0.82 (+1.05%)

USD 34.92B
HQY HealthEquity Inc

+1.49 (+1.80%)

USD 7.36B
RCM R1 RCM Inc

-0.09 (-0.71%)

USD 5.27B
GDRX Goodrx Holdings Inc

-0.17 (-2.16%)

USD 3.15B
PGNY Progyny Inc

+1.08 (+3.92%)

USD 2.46B
TXG 10X Genomics Inc

+0.35 (+1.79%)

USD 2.35B
CERT Certara Inc

-0.29 (-2.08%)

USD 2.24B
PRVA Privia Health Group Inc

+0.64 (+3.88%)

USD 2.04B
PINC Premier Inc

-0.13 (-0.70%)

USD 1.94B
BTSG BrightSpring Health Services I..

+0.03 (+0.28%)

USD 1.82B

ETFs Containing SOPH

FDHT 4.94 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.32 % 0.00 %

-0.06 (0%)

USD 0.04B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.32 % 0.00 %

-0.07 (0%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.32 % 0.00 %

-0.07 (0%)

N/A
XMLH:F Legal & General Ucits Etf.. 2.26 % 0.00 %

N/A

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 2.26 % 0.00 %

N/A

USD 0.07B
TEET:LSE VanEck Sustainable Europe.. 1.25 % 0.00 %

-0.26 (0%)

USD 0.05B
V3ET:F VanEck Vectors ETFs N.V. .. 1.25 % 0.00 %

-0.62 (0%)

USD 0.05B
TEET:SW VanEck Sustainable Europe.. 1.25 % 0.00 %

N/A

USD 0.05B
TEGB:LSE VanEck Sustainable Europe.. 1.21 % 0.00 %

N/A

USD 0.05B
EWN iShares MSCI Netherlands .. 0.00 % 0.47 %

+0.16 (+0%)

USD 0.28B
DRFD:CA Desjardins RI Developed e.. 0.00 % 0.68 %

N/A

CAD 0.19B
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

-0.04 (0%)

USD 0.06B
CACM:PA Lyxor UCITS CAC Mid 60 D-.. 0.00 % 0.00 %

-1.72 (0%)

USD 0.02B
V3ET:XETRA VanEck Sustainable Europe.. 0.00 % 0.00 %

-0.38 (0%)

USD 0.05B
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

-0.06 (0%)

USD 0.02B
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

-0.04 (0%)

USD 0.07B
W311:F HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

-0.03 (0%)

USD 0.02B
HSXU:LSE HSBC Europe Ex UK Sustain.. 0.00 % 0.00 %

-0.08 (0%)

USD 0.05B
WELL:PA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

-0.06 (0%)

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

-0.03 (0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.21% 61% D- 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.21% 61% D- 53% F
Trailing 12 Months  
Capital Gain 22.92% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.92% 81% B- 79% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.05% 54% F 30% F
Dividend Return -7.05% 52% F 29% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 50.64% 37% F 33% F
Risk Adjusted Return -13.92% 57% F 33% F
Market Capitalization 0.31B 58% F 56% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.